Archives

by in
Entry Author Date Location
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up 05/12/14 San Francisco
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Kineta, Scouring the World for Cash, Finds Oil Money 05/21/13 Seattle
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
UW Spinoff Resolve Therapeutics Lures In Takeda, Lines Up Return 02/27/13 Seattle
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
Alder Gets $3.5M Milestone as Bristol-Myers Starts Crohn’s Study 08/27/12 Seattle
Nodality Snags Pfizer Deal to Improve Autoimmune R&D, Diagnostics 08/09/12 San Francisco
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Kineta Adds $2.8M Grant 08/16/11 Seattle
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch 06/06/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
The Immunex Alumni: Where Are They Now? 01/03/11 Seattle
Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System 12/13/10 Seattle
Allozyne’s Next Drug, Made to Kill Two Birds With One Stone, Being Prepped for Clinic 11/16/10 Seattle
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
Ambit Biosciences Seeks $86M IPO as Market Warms Up 11/08/10 San Diego
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News 11/05/10 San Francisco
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle 11/04/10 San Francisco
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis 10/20/10 San Diego
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence 09/17/10 Detroit
Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients 09/16/10 San Francisco
Page 1 of 3 next page »